Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 13;8(1):24.
doi: 10.3390/bios8010024.

Calibration of Minimally Invasive Continuous Glucose Monitoring Sensors: State-of-The-Art and Current Perspectives

Affiliations
Review

Calibration of Minimally Invasive Continuous Glucose Monitoring Sensors: State-of-The-Art and Current Perspectives

Giada Acciaroli et al. Biosensors (Basel). .

Abstract

Minimally invasive continuous glucose monitoring (CGM) sensors are wearable medical devices that provide real-time measurement of subcutaneous glucose concentration. This can be of great help in the daily management of diabetes. Most of the commercially available CGM devices have a wire-based sensor, usually placed in the subcutaneous tissue, which measures a "raw" current signal via a glucose-oxidase electrochemical reaction. This electrical signal needs to be translated in real-time to glucose concentration through a calibration process. For such a scope, the first commercialized CGM sensors implemented simple linear regression techniques to fit reference glucose concentration measurements periodically collected by fingerprick. On the one hand, these simple linear techniques required several calibrations per day, with the consequent patient's discomfort. On the other, only a limited accuracy was achieved. This stimulated researchers to propose, over the last decade, more sophisticated algorithms to calibrate CGM sensors, resorting to suitable signal processing, modelling, and machine-learning techniques. This review paper will first contextualize and describe the calibration problem and its implementation in the first generation of CGM sensors, and then present the most recently-proposed calibration algorithms, with a perspective on how these new techniques can influence future CGM products in terms of accuracy improvement and calibration reduction.

Keywords: calibration; continuous glucose monitoring; diabetes; glucose sensors.

PubMed Disclaimer

Conflict of interest statement

The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Representative three days of blood glucose (BG) monitoring obtained with self-monitoring BG (SMBG), diamonds, and with continuous glucose monitoring (CGM), continuous line. Horizontal dashed lines indicate the euglycemic range. Data taken from a previously published study [15].
Figure 2
Figure 2
Examples in which the continuous glucose monitoring (CGM) sensor output (continuous line) (a) overestimates and (b) underestimates the reference blood glucose (BG) (points). Data taken from a previously published study [15].
Figure 3
Figure 3
(a) Two-compartment model describing the blood glucose to interstitial glucose (BG-to-IG) kinetics. Ra is the rate of appearance; k01,k02,k12,k21 are rate constants. The time constant of the BG-to-IG system is τ=1k02+k12. (b) Representative blood glucose (BG) (dashed line) and interstitial glucose (IG) (continuous line) concentration profiles simulated as described in the text assuming τ = 11 min.
Figure 4
Figure 4
Representative raw CGM sensor signal (continuous line, units not specified by the manufacturer) that exhibits a nonphysiological drift (dashed line) due to the time-variability of sensor sensitivity. Data were previously published in [15].

References

    1. World Health Organization (WHO) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. WHO; Geneva, Switzerland: 1999.
    1. Van Dijk H.W., Verbraak F.D., Fok P.H., Garvin M.K., Sonka M., Lee K., De Vries J.H., Michels R.P., Van Velthoven M.E., Schlingemann R.O., et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Investig. Ophthalmol. Vis. Sci. 2010;51:3660–3665. doi: 10.1167/iovs.09-5041. - DOI - PMC - PubMed
    1. Vriesendorp T.M., De Vries J.H., Van Santen S., Moeniralam H.S., De Jonge E., Roos Y.B., Schults M.J., Rosendaal F.R., Hoekstra J.B. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit. Care Med. 2006;34:2714–2718. doi: 10.1097/01.CCM.0000241155.36689.91. - DOI - PubMed
    1. Lemkes B.A., Hermanides J., De Vries J.H., Holleman F., Meijers J.C., Hoekstra J.B. Hyperglycemia: A protrombotic factor? J. Thromb. Haemost. 2010;8:1663–1669. doi: 10.1111/j.1538-7836.2010.03910.x. - DOI - PubMed
    1. You W.P., Henneberg M. Type 1 diabetes prevalence increasing globally and regionally: The role of natural selection and life expectancy at birth. BMJ Open Diabetes Res. Care. 2016;4:e000161. doi: 10.1136/bmjdrc-2015-000161. - DOI - PMC - PubMed

LinkOut - more resources